S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
CVE:COV

Covalon Technologies Stock Forecast, Price & News

C$2.65
-0.33 (-11.07 %)
(As of 09/27/2021 03:59 PM ET)
Add
Compare
Today's Range
C$2.60
C$2.90
50-Day Range
C$1.49
C$3.04
52-Week Range
C$0.92
C$3.15
Volume34,386 shs
Average Volume11,518 shs
Market CapitalizationC$68.42 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive COV News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.


About Covalon Technologies

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. The company has five proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device; aquaguard moisture barrier technology, an impermeable moisture barrier that allows the clinician or patient to cover wounds, dressings, and intravenous sites to keep them dry; and covaguard antimicrobial sanitizing technology that incorporates Benzalkonium Chloride into a lipid delivery system to surfaces and skin to kill viruses and bacteria. Its products include wound care dressings; surgical and peri-operative products; infection management products; moisture barriers; and antimicrobial sanitizers under the Covalon brand name. The company sells its products through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$27.46 million
Cash Flow
C$0.12 per share
Book Value
C$0.35 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$68.42 million
Next Earnings Date
1/27/2022 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Covalon Technologies (CVE:COV) Frequently Asked Questions

What stocks does MarketBeat like better than Covalon Technologies?

Wall Street analysts have given Covalon Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Covalon Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Covalon Technologies' next earnings date?

Covalon Technologies is scheduled to release its next quarterly earnings announcement on Thursday, January 27th 2022.
View our earnings forecast for Covalon Technologies
.

How has Covalon Technologies' stock been impacted by Coronavirus?

Covalon Technologies' stock was trading at C$1.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, COV shares have increased by 67.7% and is now trading at C$2.65.
View which stocks have been most impacted by COVID-19
.

Who are Covalon Technologies' key executives?

Covalon Technologies' management team includes the following people:
  • Mr. Brian E. Pedlar, Pres, CEO & Director
  • Mr. Danny Brannagan, Chief Financial Officer
  • Mr. Abe Schwartz, Advisor & Director
  • Simon Smith, Chief Exec. Officer of Covalon Technologies (Europe) Ltd.
  • Gerry Arambula, Pres of Covalon Technologies AG Ltd.
  • Dr. Valerio DiTizio, Co-Founder, Chief Scientific Officer & VP (Age 53)
  • Ms. Kim Crooks, VP of Operations
  • Ms. Alyssa Hrycyshyn, VP of Marketing
  • Mr. Greg Leszczynski, VP of HR
  • Mr. Hamed Abbasian, VP of Bus. Devel.

What other stocks do shareholders of Covalon Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covalon Technologies investors own include Shopify (SHOP), Bausch Health Companies (BHC), Carbon Black (CBLK), Great Canadian Gaming (GC), Canada Goose (GOOS), Kirkland Lake Gold (KL), Kinaxis (KXS), Lightspeed POS (LSPD), NIO (NIO) and NVIDIA (NVDA).

What is Covalon Technologies' stock symbol?

Covalon Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "COV."

How do I buy shares of Covalon Technologies?

Shares of COV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Covalon Technologies' stock price today?

One share of COV stock can currently be purchased for approximately C$2.65.

How much money does Covalon Technologies make?

Covalon Technologies has a market capitalization of C$68.42 million and generates C$27.46 million in revenue each year.

What is Covalon Technologies' official website?

The official website for Covalon Technologies is www.covalon.com.

Where are Covalon Technologies' headquarters?

Covalon Technologies is headquartered at 1660 Tech Ave Unit 5, MISSISSAUGA, ON L4W 5S7, Canada.

How can I contact Covalon Technologies?

Covalon Technologies' mailing address is 1660 Tech Ave Unit 5, MISSISSAUGA, ON L4W 5S7, Canada. The company can be reached via phone at +1-905-5688400.


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.